1. Home
  2. TIVC vs PPCB Comparison

TIVC vs PPCB Comparison

Compare TIVC & PPCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tivic Health Systems Inc.

TIVC

Tivic Health Systems Inc.

HOLD

Current Price

$0.81

Market Cap

2.8M

Sector

Health Care

ML Signal

HOLD

PPCB

Propanc Biopharma Inc.

N/A

Current Price

$0.17

Market Cap

3.2M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
TIVC
PPCB
Founded
2016
2007
Country
United States
Australia
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8M
3.2M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
TIVC
PPCB
Price
$0.81
$0.17
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
31.1K
1.5M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$780,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.75
$0.16
52 Week High
$13.20
$10.69

Technical Indicators

Market Signals
Indicator
TIVC
PPCB
Relative Strength Index (RSI) 34.39 30.69
Support Level $0.76 $0.16
Resistance Level $1.36 $0.40
Average True Range (ATR) 0.06 0.02
MACD 0.02 0.01
Stochastic Oscillator 25.02 11.95

Price Performance

Historical Comparison
TIVC
PPCB

About TIVC Tivic Health Systems Inc.

Tivic Health Systems Inc is a health technology company focused on developing and commercializing non-invasive bioelectronic medicine. The company's platform-based technology activates the body's own healing mechanisms and can be programmed to treat various disease conditions. company's products provide a natural alternative to the standard synthetic chemical methods used by the pharmaceutical industry. ClearUP Sinus Relief, is a first commercial product of the company which is a patented handled device that uses ultra-low current electrical waves to relieve sinus pain and congestion symptoms that are prevalent in nasal allergies, sinus infections, chronic sinusitis, cold and flu and other disease conditions.

About PPCB Propanc Biopharma Inc.

Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.

Share on Social Networks: